Alpha adrenergic neurons inhibit luteinizing hormone pulse amplitude in breeding season ewes.
It is now clear that estradiol acts in the brain to inhibit LH pulse amplitude in breeding season ewes, but the neural mechanisms underlying this action of estradiol have yet to be determined. In this study, we performed four experiments to examine the role of alpha-adrenergic neurons in the control of LH pulse amplitude in the ewe. In the first experiment, implantation of the alpha-adrenergic antagonist phenoxybenzamine into the preoptic area (POA) during the follicular phase of the ovine estrous cycle significantly increased LH pulse amplitude. A similar stimulatory effect of POA implants of this antagonist was observed in estradiol-treated ovariectomized (OVX+E) ewes, but phenoxybenzamine implants had no effect in the absence of estradiol. In contrast, systemic administration of phenoxybenzamine decreased LH pulse amplitude in both OVX and OVX+E ewes. Finally, POA implants of the alpha 1-adrenergic antagonist, prazosin, increased LH pulse amplitude in OVX+E ewes, whereas the alpha 2-adrenergic antagonist, yohimbine, had no effect in these animals. These results suggest that a noradrenergic (or adrenergic) system acts in the POA via alpha 1-adrenergic receptors to inhibit LH pulse amplitude in the ewe. They also raise the possibility that this system may be involved in the negative feedback action of estradiol during the breeding season.
Goodman
R L
RL
Department of Physiology, West Virginia University Health Sciences Center, Morgantown 26506, USA.
Havern
R L
RL
Whisnant
C S
CS
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D004343:Drug Implants; D004958:Estradiol / Q000494:pharmacology; D005246:Feedback; D005260:Female; D007986:Luteinizing Hormone / Q000378:metabolism*; D009474:Neurons / Q000502:physiology*; D010052:Ovariectomy; D010643:Phenoxybenzamine / Q000008:administration & dosage / Q000494:pharmacology; D011224:Prazosin / Q000008:administration & dosage / Q000494:pharmacology; D011301:Preoptic Area / Q000187:drug effects; D011942:Receptors, Adrenergic, alpha / Q000502:physiology*; D012098:Reproduction / Q000502:physiology*; D012621:Seasons; D012756:Sheep / Q000502:physiology*; D015016:Yohimbine / Q000008:administration & dosage / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D004343:Drug Implants; D011942:Receptors, Adrenergic, alpha; D010643:Phenoxybenzamine; D015016:Yohimbine; D004958:Estradiol; D007986:Luteinizing Hormone; D011224:Prazosin